Given the success in stabilizing vision with current anti-vascular endothelial growth factor (VEGF) options, one main target for future anti-VEGF drug development includes creating medications with longer durations of action. Achieving this goal will decrease the number of overall injections and follow-up visits required to ensure better patient compliance. The smallest anti-VEGF created so far is brolucizumab (Beovu; Novartis). It is a 26-kDa IgG single-chain antibody fragment that delivers 11 times more anti-VEGF per injection than aflibercept. Brolucizumab was approved by the U.S. Food and Drug Administration (FDA) in late 2019 for the treatment of wet age-related macular degeneration, and has been also approved for the same indication in Japan and the European Union in 2020. In this article, we compare brolucizumab to current FDA-approved anti-VEGF treatments, address the studies associated with brolucizumab, discuss brolucizumab's side effects, and conclude with recommendations.

Download full-text PDF

Source
http://dx.doi.org/10.1358/dot.2020.56.11.3199812DOI Listing

Publication Analysis

Top Keywords

treatment wet
8
wet age-related
8
brolucizumab
5
brolucizumab treatment
4
age-related maculopathy
4
maculopathy success
4
success stabilizing
4
stabilizing vision
4
vision current
4
current anti-vascular
4

Similar Publications

Firefighters are exposed to the risk of burns at fire scenes. In 2020, the National Fire Agency of the Republic of Korea surveyed 50,527 firefighters and identified 242 burn-related incidents. The body parts affected by these burns were the hands (28.

View Article and Find Full Text PDF

The quality grade of cow meat is often lower than that of steer meat, resulting in economic losses and reduced consumer satisfaction. This review explores various strategies for improving the quality of cow meat, with a focus on slaughter and post-slaughter practices. Certain slaughter methods, including electrical stimulation and suspension techniques, have been shown to improve meat tenderness by alleviating rigor mortis and inducing an increase in sarcomere length.

View Article and Find Full Text PDF

A bird's-eye view of the biological mechanism and machine learning prediction approaches for cell-penetrating peptides.

Front Artif Intell

January 2025

Department of Genetic Engineering, Computational Biology Lab, School of Bioengineering, SRM Institute of Science and Technology, SRM Nagar, Chennai, India.

Cell-penetrating peptides (CPPs) are highly effective at passing through eukaryotic membranes with various cargo molecules, like drugs, proteins, nucleic acids, and nanoparticles, without causing significant harm. Creating drug delivery systems with CPP is associated with cancer, genetic disorders, and diabetes due to their unique chemical properties. Wet lab experiments in drug discovery methodologies are time-consuming and expensive.

View Article and Find Full Text PDF

Trauma care prioritizes life-threatening conditions using the ABCDE algorithm based on the principle "treat first what kills first". As for catastrophic hemorrhage, a leading preventable cause of death in trauma, modifications of this algorithm are necessary in specific cases. In cold climates, life-threatening hypothermia poses additional challenges.

View Article and Find Full Text PDF

Extracts of plants have been used to manage various insect pests, but little information is available about how effective they are in reducing crop damage or how they affect crop yield and beneficial insects in rice. Extracts from leaves, leaves, leaves, leaves, cloves, and fruits, known to have insecticidal properties, were compared with two checks, viz., Azadirachtin 1% EC and standard insecticide Acephate 95 SG, for their efficacy against yellow stem borer (YSB), (Walk.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!